Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration

PURPOSE: To evaluate the durability of fixed bimonthly dosing of intravitreal aflibercept for neovascular age-related macular degeneration. METHODS: Records of 16 patients were retrospectively reviewed. Patients received three initial 2.0 mg monthly doses of aflibercept then 8-weekly doses according...

Descripción completa

Detalles Bibliográficos
Autor principal: Khanani, Arshad M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516180/
https://www.ncbi.nlm.nih.gov/pubmed/26229424
http://dx.doi.org/10.2147/OPTH.S88624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516180/
https://www.ncbi.nlm.nih.gov/pubmed/26229424
http://dx.doi.org/10.2147/OPTH.S88624

Ejemplares similares